Insider Transactions last 24 months for Ocular Therapeutix, Inc.  -  NSDQ: OCUL

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Dugel PravinSee Remarks09/09/2025AGIndirectCOM49,754$0.00$0.0049,754
Dugel PravinSee Remarks09/09/2025DGDirectCOM49,754$0.00$0.003,177,490
Notman DonaldSee Remarks09/02/2025DSDirectCOM1,066$12.43$13,250.38308,807
Dugel PravinSee Remarks08/25/2025DSDirectCOM21,494$12.04$258,787.763,227,244
Heier Jeffrey S.Chief Scientific Officer08/25/2025DSDirectCOM3,063$12.04$36,878.52259,911
Nayak SanjayChief Strategy Officer08/25/2025DSDirectCOM1,885$12.04$22,695.40279,738
Kaiser PeterChief Development Officer08/25/2025DSDirectCOM3,011$12.04$36,252.44204,093
Waheed NadiaChief Medical Officer08/12/2025AADirectCOM40,363$0.00$0.00247,168
Dugel PravinSee Remarks08/11/2025AGIndirectCOM250,361$0.00$0.00250,361
Dugel PravinSee Remarks06/12/2025DGDirectCOM50,029$0.00$0.003,248,738
Graves Adrienne LDirector06/11/2025AADirectCOM14,000$0.00$0.0050,000
Warden Charles MDirector06/11/2025AADirectCOM14,000$0.00$0.0086,464
Williams Leslie J.Director06/11/2025AADirectCOM14,000$0.00$0.0051,433
Lindstrom Richard L MdDirector06/11/2025AADirectCOM14,000$0.00$0.00143,145
Raines MerileeDirector06/11/2025AADirectCOM14,000$0.00$0.0046,933
Hong Seung SuhDirector06/11/2025AADirectCOM14,000$0.00$0.0046,933
Waheed NadiaChief Medical Officer06/02/2025DSDirectCOM13,861$8.05$111,581.05206,805
Dugel PravinSee Remarks05/23/2025DSDirectCOM21,219$7.18$152,352.423,499,099
Heier Jeffrey S.Chief Scientific Officer05/23/2025DSDirectCOM3,024$7.18$21,712.32262,974
Kaiser PeterChief Development Officer05/23/2025DSDirectCOM2,974$7.17$21,323.58207,104
Nayak SanjayChief Strategy Officer05/23/2025DSDirectCOM1,862$7.17$13,350.54281,623
Lindstrom Richard L MdDirector05/08/2025APDirectCOM10,000$6.96$69,600.00172,704
Dugel PravinSee Remarks04/28/2025DGDirectCOM200,332$0.00$0.003,298,767
Nayak SanjayChief Strategy Officer02/24/2025DSDirectCOM1,895$6.84$12,961.80283,485
Kaiser PeterChief Development Officer02/24/2025DSDirectCOM3,009$6.87$20,671.83210,078
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel